Activated protein C resistance caused by a common factor V mutation has a single origin

Thrombosis Research

Volumn 85, Issue 3, 1997, Pages 237-243

  Zöller, Bengt ^a   Hillarp, Andreas ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

APC resistance; factor V; haplotype; hypercoagulation; mutation; thrombosis

Indexed keywords

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; AGED; BASE SEQUENCE; EXONS; FACTOR V; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN C; RESTRICTION MAPPING; SWEDEN;

EID: 0031079750     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00008-X     Document Type: Article

References (22)

1. DAHLBÄCK B., CARLSSON M., SVENSSON P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein. C. Proc Natl Acad Sci USA. 90:1993;1004-1008.
2. GRIFFIN J.H., EVATT B.L., WIDEMAN C., FERNANDEZ J.A. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood. 82:1993;1989-1993.
3. KOSTER T., ROSENDAAL F.R., DE RONDE F., BRIËT E., VANDENBROUCKE J.P., BERTINA R.M. Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet. 342:1993;1503-1506.
4. HALBMAYER W.M., HAUSHOFER A., SCHÖN R., FISCHER M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis. 5:1994;51-57.
5. SVENSSON P.J., DAHLBÄCK B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 330:1994;517-521.
6. BERTINA R.M., KOELEMAN B.P.C., KOSTER T., ROSENDAAL F.R., DIRVEN R.J., DE RONDE H., VAN DER VELDEN P.A., REITSMA P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
7. GREENGARD J.S., SUN X., XU X., FERNANDEZ J.A., GRIFFIN J.H., EVATT B.L. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 343:1994;1362-1363.
8. VOORBERG J., ROELSE J., KOOPMAN R., BÜLLER H., BERENDS F., TEN CATE J.W., MERTENS K., VAN MOURIK J.A. Association of idiopathic thromboembolism with single point mutation at Arg506 of factor V. Lancet. 343:1994;1535-1536.
9. ZÖLLER B., DAHLBÄCK B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 343:1994;1536-1538.
10. ZÖLLER B., SVENSSON P.J., HE X., DAHLBÄCK B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 94:1994;2521-2524.
11. R506Q. J Biol Chem. 270:1995;4053-4057.
12. HEEB M.J., KOJIMA Y., GREENGARD J.S., GRIFFIN J.H. Activated protein C resistance: Molecular mechanisms based on studies using purified Gln506-factor V. Blood. 85:1995;3405-3411.
13. R506Q by activated protein C. J Biol Chem. 270:1995;21158-21166.
14. WANG H., RIDELL D.C., GUINTO E.R., MacGILLIVRAY R.T.A., HAMERTON J.L. Localization of the gene encoding human factor V to chromosome 1q21-25. Genomics. 2:1988;234-328.
15. JENNY R.J., PITTMAN D.D., TOOLE J.J., KRIZ R.W., ALDAPE R.A., HEWICK R.M., KAUFMAN R.J., MANN K.G. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA. 84:1987;4846-4850.
16. CRIPE L.D., MOORE K.D., KANE W.H. Structure of the gene for human coagulation factor V. Biochemistry. 31:1992;3777-3785.
17. SHEN N.L.L., FAN S.T., PYATI J., GRAFF R., LAPOLLA R.J., EDGINGTON T.S. The serine protease cofactor factor V is synthesized by lymphocytes. J Immunol. 150:1993;2992-3001.
18. LUNGHI B., LACOVIELLI L., GEMMATI D., DILASIO M.G., CASTOLDI E., PINOTTI M., CASTAMAN G., REDAELLI R., MARIANI G., MARCHETTI G., BERNARDI F. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost. 75:1996;45-48.
19. COX M., REES D.C., MARTINSSON J.J., CLEGG J.B. Evidence for a single origin of factor V Leiden. Br J Haematol. 92:1996;1022-1025.
20. REES D.C., COX M., CLEGG J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.
21. HOLM J., ZÖLLER B., BERNTORP E., ERHARDT L., DAHLBÄCK B. Prevalence of factor V gene mutation among myocardial infarction patients and healthy controls higher in Sweden than in other countries. J Intern Med. 239:1996;221-226.
22. ZÖLLER B., NORLUND L., LEKSELL H., NILSSON J-E., VON SCHENCK H., ROSEN U., JEPPSSON J-O., DAHLBÄCK B. High prevalence of the FV:R506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. Thromb Res. 83:1996;475-477.